Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Sicard

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
La Revue Du Praticien|May 24, 2014
[Organ transplantation]Antoine Sicard, Cécile Chauvet, Emmanuel Morelon
HLA|March 2, 2022
Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipientsMarion Cremoni, Filippo Massa, Antoine Sicard
La Revue Du Praticien|May 24, 2014
[The fight against the organ shortage]Antoine Sicard, Cécile Chauvet, Emmanuel Morelon
La Revue Du Praticien|October 5, 2023
[Organ transplantation]Alexandre Gérard, Antoine Sicard, Cécile Chauvet, et al.
Current Opinion in Organ Transplantation|August 1, 2018
Taking regulatory T-cell therapy one step furtherAntoine Sicard, Dominic A Boardman, Megan K Levings
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2018
Engineering therapeutic T cells to suppress alloimmune responses using TCRs, CARs, or BARsAntoine Sicard, Megan K Levings, David W Scott
La Revue Du Praticien|October 5, 2023
Alexandre Gérard, Antoine Sicard, Cécile Chauvet, et al.
Current Opinion in Organ Transplantation|June 4, 2016
Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejectionAntoine Sicard, Chien-Chia Chen, Emmanuel Morelon, et al.
Frontiers in Immunology|April 24, 2015
Cell therapy to induce allograft tolerance: time to switch to plan B?Antoine Sicard, Alice Koenig, Emmanuel Morelon, et al.
Transplantation|February 11, 2020
Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience?Antoine Sicard, Jean Kanitakis, Valérie Dubois, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
La Revue Du Praticien|May 24, 2014
[Organ transplantation]Antoine Sicard, Cécile Chauvet, Emmanuel Morelon
HLA|March 2, 2022
Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipientsMarion Cremoni, Filippo Massa, Antoine Sicard
La Revue Du Praticien|May 24, 2014
[The fight against the organ shortage]Antoine Sicard, Cécile Chauvet, Emmanuel Morelon
La Revue Du Praticien|October 5, 2023
[Organ transplantation]Alexandre Gérard, Antoine Sicard, Cécile Chauvet, et al.
Current Opinion in Organ Transplantation|August 1, 2018
Taking regulatory T-cell therapy one step furtherAntoine Sicard, Dominic A Boardman, Megan K Levings
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2018
Engineering therapeutic T cells to suppress alloimmune responses using TCRs, CARs, or BARsAntoine Sicard, Megan K Levings, David W Scott
La Revue Du Praticien|October 5, 2023
Alexandre Gérard, Antoine Sicard, Cécile Chauvet, et al.
Current Opinion in Organ Transplantation|June 4, 2016
Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejectionAntoine Sicard, Chien-Chia Chen, Emmanuel Morelon, et al.
Frontiers in Immunology|April 24, 2015
Cell therapy to induce allograft tolerance: time to switch to plan B?Antoine Sicard, Alice Koenig, Emmanuel Morelon, et al.
Transplantation|February 11, 2020
Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience?Antoine Sicard, Jean Kanitakis, Valérie Dubois, et al.
Pageof 7